{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:34:08Z","timestamp":1773048848254,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,10,27]],"date-time":"2007-10-27T00:00:00Z","timestamp":1193443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00401-007-0310-x","type":"journal-article","created":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T01:29:47Z","timestamp":1193362187000},"page":"249-259","source":"Crossref","is-referenced-by-count":57,"title":["Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach"],"prefix":"10.1007","volume":"115","author":[{"given":"David","family":"Capper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Mittelbronn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Meyermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Schittenhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,27]]},"reference":[{"key":"310_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1179\/016164103101201445","volume":"25","author":"T Anda","year":"2003","unstructured":"Anda T, Shabani HK, Tsunoda K, Tokunaga Y, Kaminogo M, Shibata S, Hayashi T, Iseki M (2003) Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysis. Neurol Res 25:241\u2013248","journal-title":"Neurol Res"},{"key":"310_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/B:NEON.0000033385.37098.85","volume":"68","author":"JL Blanc","year":"2004","unstructured":"Blanc JL, Wager M, Guilhot J, Kusy S, Bataille B, Chantereau T, Lapierre F, Larsen CJ, Karayan-Tapon L (2004) Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas. J Neurooncol 68:275\u2013283","journal-title":"J Neurooncol"},{"key":"310_CR3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1158\/0008-5472.CAN-06-2782","volume":"67","author":"MD Blough","year":"2007","unstructured":"Blough MD, Zlatescu MC, Cairncross JG (2007) O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells. Cancer Res 67:580\u2013584","journal-title":"Cancer Res"},{"key":"310_CR4","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1158\/1078-0432.CCR-05-0230","volume":"11","author":"M Brell","year":"2005","unstructured":"Brell M, Tortosa A, Verger E, Gil JM, Vi\u00f1olas N, Vill\u00e1 S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F (2005) Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 11:5167\u20135174","journal-title":"Clin Cancer Res"},{"key":"310_CR5","first-page":"58","volume":"50","author":"TP Brent","year":"1990","unstructured":"Brent TP, von Wronski M, Pegram CN, Bigner DD (1990) Immunoaffinity purification of human O6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies. Cancer Res 50:58\u201361","journal-title":"Cancer Res"},{"key":"310_CR6","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2005.04.3414","volume":"24","author":"G Cairncross","year":"2006","unstructured":"Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, Mehta M, Curran W (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: intergroup radiation therapy oncology group trial 9402. J Clin Oncol 24:2707\u20132714","journal-title":"J Clin Oncol"},{"key":"310_CR7","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.2006.07.4807","volume":"25","author":"OL Chinot","year":"2007","unstructured":"Chinot OL, Barri\u00e9 M, Fuentes S, Eudes N, Lancelot S, Metellus P, Muracciole X, Braguer D, Ouafik L, Martin PM, Dufour H, Figarella-Branger D (2007) Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. J Clin Oncol 25:1470\u20131475","journal-title":"J Clin Oncol"},{"key":"310_CR8","first-page":"49","volume":"7","author":"M Citron","year":"1996","unstructured":"Citron M, White A, Decker R, Wasserman P, Li B, Randall T, Guerra D, Belanich M, Yarosh D (1996) O6-methylguanine-DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies. Oncol Res 7:49\u201355","journal-title":"Oncol Res"},{"key":"310_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0921-8777(95)00058-5","volume":"363","author":"TM Crone","year":"1996","unstructured":"Crone TM, Goodtzova K, Pegg AE (1996) Amino acid residues affecting the activity and stability of human O6-alkylguanine-DNA alkyltransferase. Mutat Res 363:15\u201325","journal-title":"Mutat Res"},{"key":"310_CR10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pbc.20803","volume":"48","author":"AM Donson","year":"2007","unstructured":"Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK (2007) MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer 48:403\u2013407","journal-title":"Pediatr Blood Cancer"},{"key":"310_CR11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","volume":"343","author":"M Esteller","year":"2000","unstructured":"Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350\u20131354","journal-title":"N Engl J Med"},{"key":"310_CR12","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.1998.16.12.3851","volume":"16","author":"HS Friedman","year":"1998","unstructured":"Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, Ashley DM, Krischer J, Lovell S, Rasheed K, Marchev F, Seman AJ, Cokgor I, Rich J, Stewart E, Colvin OM, Provenzale JM, Bigner DD, Haglund MM, Friedman AH, Modrich PL (1998) DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 16:3851\u20133857","journal-title":"J Clin Oncol"},{"key":"310_CR13","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1128\/MCB.11.9.4660","volume":"11","author":"G Fritz","year":"1991","unstructured":"Fritz G, Tano K, Mitra S, Kaina B (1991) Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments. Mol Cell Biol 11:4660\u20134668","journal-title":"Mol Cell Biol"},{"key":"310_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1155\/2007\/159242","volume":"23","author":"P Hau","year":"2007","unstructured":"Hau P, Stupp R, Hegi ME (2007) MGMT methylation status: the advent of stratified therapy in glioblastoma? Dis Markers 23:97\u2013104","journal-title":"Dis Markers"},{"key":"310_CR15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1078-0432.CCR-03-0384","volume":"10","author":"ME Hegi","year":"2004","unstructured":"Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N, Stupp R (2004) Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10:1871\u20131874","journal-title":"Clin Cancer Res"},{"key":"310_CR16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003","journal-title":"N Engl J Med"},{"key":"310_CR17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1471-4159.2005.03583.x","volume":"96","author":"M Hermisson","year":"2006","unstructured":"Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, Kaina B, Weller M (2006) O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem 96:766\u2013776","journal-title":"J Neurochem"},{"key":"310_CR18","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.1998.16.10.3310","volume":"16","author":"KA Jaeckle","year":"1998","unstructured":"Jaeckle KA, Eyre HJ, Townsend JJ, Schulman S, Knudson HM, Belanich M, Yarosh DB, Bearman SI, Giroux DJ, Schold SC (1998) Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a southwest oncology group study. J Clin Oncol 16:3310\u20133315","journal-title":"J Clin Oncol"},{"key":"310_CR19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1227\/01.NEU.0000103422.51382.99","volume":"54","author":"T Kamiryo","year":"2004","unstructured":"Kamiryo T, Tada K, Shiraishi S, Shinojima N, Kochi M, Ushio Y (2004) Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea-based chemotherapy. Neurosurgery 54:349\u2013357","journal-title":"Neurosurgery"},{"key":"310_CR20","volume-title":"Pathology and genetics of tumours of the nervous system","author":"P Kleihues","year":"2000","unstructured":"Kleihues P, Cavenee WK (2000) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon"},{"key":"310_CR21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1750-3639.2003.tb00017.x","volume":"13","author":"C Komine","year":"2003","unstructured":"Komine C, Watanabe T, Katayama Y, Yoshino A, Yokoyama T, Fukushima T (2003) Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas. Brain Pathol 13:176\u2013184","journal-title":"Brain Pathol"},{"key":"310_CR22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/carcin\/bgg005","volume":"24","author":"GP Margison","year":"2003","unstructured":"Margison GP, Povey AC, Kaina B, Santib\u00e1\u00f1ez Koref MF (2003) Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis 24:625\u2013635","journal-title":"Carcinogenesis"},{"key":"310_CR23","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1158\/1535-7163.MCT-06-0106","volume":"5","author":"JA Maxwell","year":"2006","unstructured":"Maxwell JA, Johnson SP, Quinn JA, McLendon RE, Ali-Osman F, Friedman AH, Herndon JE, Bierau K, Bigley J, Bigner DD, Friedman HS (2006) Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma. Mol Cancer Ther 5:2531\u20132539","journal-title":"Mol Cancer Ther"},{"key":"310_CR24","first-page":"643","volume":"78","author":"RE McLendon","year":"1998","unstructured":"McLendon RE, Cleveland L, Pegram C, Bigner SH, Bigner DD, Friedman HS (1998) Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas. Lab Invest 78:643\u2013644","journal-title":"Lab Invest"},{"key":"310_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1620\/tjem.165.223","volume":"165","author":"K Mineura","year":"1991","unstructured":"Mineura K, Izumi I, Watanabe K, Kowada M (1991) O6-alkylguanine-DNA alkyltransferase activity in human brain tumors. Tohoku J Exp Med 165:223\u2013228","journal-title":"Tohoku J Exp Med"},{"key":"310_CR26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/(SICI)1097-0215(19961021)69:5<420::AID-IJC12>3.0.CO;2-6","volume":"69","author":"K Mineura","year":"1996","unstructured":"Mineura K, Yanagisawa T, Watanabe K, Kowada M, Yasui N (1996) Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy. Int J Cancer 69:420\u2013425","journal-title":"Int J Cancer"},{"key":"310_CR27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2990.2006.00820.x","volume":"33","author":"M Mittelbronn","year":"2007","unstructured":"Mittelbronn M, Capper D, Bunz B, Dietz K, Goeppert B, Ajaaj R, Tabatabai G, Stubenvoll F, Schlaszus H, Merseburger AS, Becker R, Freudenstein D, Wick W, Weller M, Meyermann R, Simon P (2007) De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival. Neuropathol Appl Neurobiol 33:299\u2013307","journal-title":"Neuropathol Appl Neurobiol"},{"key":"310_CR28","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/carcin\/22.10.1715","volume":"22","author":"M Nakamura","year":"2001","unstructured":"Nakamura M, Watanabe T, Yonekawa Y, Kleihues P, Ohgaki H (2001) Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C\u00a0\u2192\u00a0A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis 22:1715\u20131719","journal-title":"Carcinogenesis"},{"key":"310_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11060-004-9170-6","volume":"70","author":"S Nakasu","year":"2004","unstructured":"Nakasu S, Fukami T, Baba K, Matsuda M (2004) Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas. J Neurooncol 70:333\u2013340","journal-title":"J Neurooncol"},{"key":"310_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/002215540505300102","volume":"53","author":"S Namimatsu","year":"2005","unstructured":"Namimatsu S, Ghazizadeh M, Sugisaki Y (2005) Reversing the effects of formalin fixation with citraconic anhydride and heat: a universal antigen retrieval method. J Histochem Cytochem 53:3\u201311","journal-title":"J Histochem Cytochem"},{"key":"310_CR31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479\u2013489","journal-title":"J Neuropathol Exp Neurol"},{"key":"310_CR32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","volume":"170","author":"H Ohgaki","year":"2007","unstructured":"Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445\u20131453","journal-title":"Am J Pathol"},{"key":"310_CR33","first-page":"543","volume":"22","author":"N Ohe","year":"2003","unstructured":"Ohe N, Saio M, Kijima M, Tamakawa N, Suwa T, Kojima Y, Yano H, Kaku Y, Iwama T, Shinoda J, Sakai N, Takami T (2003) In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors. Int J Oncol 22:543\u2013549","journal-title":"Int J Oncol"},{"key":"310_CR34","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1158\/1078-0432.CCR-04-0392","volume":"10","author":"MF Paz","year":"2004","unstructured":"Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, Aguirre-Cruz L, Garc\u00eda-Lopez JL, Piquer J, Safont MJ, Bala\u00f1a C, Sanchez-Cespedes M, Garc\u00eda-Villanueva M, Arribas L, Esteller M (2004) CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res 10:4933\u20134938","journal-title":"Clin Cancer Res"},{"key":"310_CR35","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2006.05.7265","volume":"24","author":"IF Pollack","year":"2006","unstructured":"Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL (2006) O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. J Clin Oncol 24:3431\u20133437","journal-title":"J Clin Oncol"},{"key":"310_CR36","first-page":"130","volume":"20","author":"I Preuss","year":"1996","unstructured":"Preuss I, Haas S, Eichhorn U, Eberhagen I, Kaufmann M, Beck T, Eibl RH, Dall P, Bauknecht T, Hengstler J, Wittig BM, Dippold W, Kaina B (1996) Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Cancer Detect Prev 20:130\u2013136","journal-title":"Cancer Detect Prev"},{"key":"310_CR37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<416::AID-IJC15>3.0.CO;2-A","volume":"84","author":"C Rolhion","year":"1999","unstructured":"Rolhion C, Penault-Llorca F, Kemeny JL, Kwiatkowski F, Lemaire JJ, Chollet P, Finat-Duclos F, Verrelle P (1999) O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int J Cancer 84:416\u2013420","journal-title":"Int J Cancer"},{"key":"310_CR38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.critrevonc.2006.04.005","volume":"60","author":"ML Siker","year":"2006","unstructured":"Siker ML, Chakravarti A, Mehta MP (2006) Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Crit Rev Oncol Hematol 60:99\u2013111","journal-title":"Crit Rev Oncol Hematol"},{"key":"310_CR39","first-page":"3416","volume":"53","author":"JR Silber","year":"1993","unstructured":"Silber JR, Mueller BA, Ewers TG, Berger MS (1993) Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53:3416\u20133420","journal-title":"Cancer Res"},{"key":"310_CR40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research, Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"310_CR41","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1200\/JCO.2006.09.7139","volume":"25","author":"R Stupp","year":"2007","unstructured":"Stupp R, Hegi ME (2007) Methylguanine methyltransferase testing in glioblastoma: when and how? J Clin Oncol 25:1459\u20131460","journal-title":"J Clin Oncol"},{"key":"310_CR42","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10571-005-8475-0","volume":"25","author":"S Tanaka","year":"2005","unstructured":"Tanaka S, Oka H, Fujii K, Watanabe K, Nagao K, Kakimoto A (2005) Quantitation of O6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas. Cell Mol Neurobiol 25:1067\u20131071","journal-title":"Cell Mol Neurobiol"},{"key":"310_CR43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3171\/jns.2004.101.4.0659","volume":"101","author":"S Ueda","year":"2004","unstructured":"Ueda S, Mineta T, Nakahara Y, Okamoto H, Shiraishi T, Tabuchi K (2004) Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg 101:659\u2013663","journal-title":"J Neurosurg"},{"key":"310_CR44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1750-3639.1996.tb00848.x","volume":"6","author":"K Watanabe","year":"1996","unstructured":"Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217\u2013223","journal-title":"Brain Pathol"},{"key":"310_CR45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ijc.20625","volume":"113","author":"T Watanabe","year":"2005","unstructured":"Watanabe T, Katayama Y, Komine C, Yoshino A, Ogino A, Ohta T, Fukushima T (2005) O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course. Int J Cancer 113:581\u2013587","journal-title":"Int J Cancer"},{"key":"310_CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1750-3639.2006.00030.x","volume":"17","author":"T Watanabe","year":"2007","unstructured":"Watanabe T, Katayama Y, Yoshino A, Yachi K, Ohta T, Ogino A, Komine C, Fukushima T (2007) Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression. Brain Pathol 17:5\u201310","journal-title":"Brain Pathol"},{"key":"310_CR47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00001813-199701000-00013","volume":"8","author":"SR Wedge","year":"1997","unstructured":"Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES (1997) In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 8:92\u201397","journal-title":"Anticancer Drugs"},{"key":"310_CR48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1440-1789.2003.00504.x","volume":"23","author":"Q Yuan","year":"2003","unstructured":"Yuan Q, Matsumoto K, Nakabeppu Y, Iwaki T (2003) A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas. Neuropathology 23:203\u2013209","journal-title":"Neuropathology"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-007-0310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-007-0310-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-007-0310-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:23:15Z","timestamp":1559049795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-007-0310-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,27]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1007\/s00401-007-0310-x","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,27]]}}}